Australia Markets closed

ResMed Inc. (RMD)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
210.65+0.06 (+0.03%)
As of 10:18AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.47
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3253.67
52-week low 3189.40
50-day moving average 3218.10
200-day moving average 3220.42

Share statistics

Avg vol (3-month) 3662.65k
Avg vol (10-day) 3740.09k
Shares outstanding 5146.91M
Implied shares outstanding 6N/A
Float 8145.5M
% held by insiders 11.31%
% held by institutions 165.52%
Shares short (12 Jan 2023) 4849.96k
Short ratio (12 Jan 2023) 41.33
Short % of float (12 Jan 2023) 40.66%
Short % of shares outstanding (12 Jan 2023) 40.58%
Shares short (prior month 14 Dec 2022) 4950.06k

Dividends & splits

Forward annual dividend rate 41.76
Forward annual dividend yield 40.80%
Trailing annual dividend rate 31.56
Trailing annual dividend yield 30.74%
5-year average dividend yield 40.97
Payout ratio 431.33%
Dividend date 315 Mar 2023
Ex-dividend date 407 Feb 2023
Last split factor 22:1
Last split date 330 Aug 2010

Financial highlights

Fiscal year

Fiscal year ends 29 June 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 21.51%
Operating margin (ttm)28.03%

Management effectiveness

Return on assets (ttm)11.55%
Return on equity (ttm)23.52%

Income statement

Revenue (ttm)3.76B
Revenue per share (ttm)25.70
Quarterly revenue growth (yoy)15.50%
Gross profit (ttm)2.06B
Net income avi to common (ttm)809.47M
Diluted EPS (ttm)3.13
Quarterly earnings growth (yoy)11.50%

Balance sheet

Total cash (mrq)258.18M
Total cash per share (mrq)1.76
Total debt (mrq)1.94B
Total debt/equity (mrq)51.88
Current ratio (mrq)3.17
Book value per share (mrq)18.62

Cash flow statement

Operating cash flow (ttm)370.22M
Levered free cash flow (ttm)124.38M